184 related articles for article (PubMed ID: 11495720)
1. The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation.
Ilsley JL; Sudol M; Winder SJ
Cell Signal; 2001 Sep; 13(9):625-32. PubMed ID: 11495720
[TBL] [Abstract][Full Text] [Related]
2. The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.
Rentschler S; Linn H; Deininger K; Bedford MT; Espanel X; Sudol M
Biol Chem; 1999 Apr; 380(4):431-42. PubMed ID: 10355629
[TBL] [Abstract][Full Text] [Related]
3. Epitopes in the interacting regions of beta-dystroglycan (PPxY motif) and dystrophin (WW domain).
Pereboev AV; Ahmed N; thi Man N; Morris GE
Biochim Biophys Acta; 2001 Jul; 1527(1-2):54-60. PubMed ID: 11420143
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.
Jung D; Yang B; Meyer J; Chamberlain JS; Campbell KP
J Biol Chem; 1995 Nov; 270(45):27305-10. PubMed ID: 7592992
[TBL] [Abstract][Full Text] [Related]
5. Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.
Huang X; Poy F; Zhang R; Joachimiak A; Sudol M; Eck MJ
Nat Struct Biol; 2000 Aug; 7(8):634-8. PubMed ID: 10932245
[TBL] [Abstract][Full Text] [Related]
6. Spatial relationship of the C-terminal domains of dystrophin and beta-dystroglycan in cardiac muscle support a direct molecular interaction at the plasma membrane interface.
Stevenson S; Rothery S; Cullen MJ; Severs NJ
Circ Res; 1998 Jan 9-23; 82(1):82-93. PubMed ID: 9440707
[TBL] [Abstract][Full Text] [Related]
7. Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.
James M; Nuttall A; Ilsley JL; Ottersbach K; Tinsley JM; Sudol M; Winder SJ
J Cell Sci; 2000 May; 113 ( Pt 10)():1717-26. PubMed ID: 10769203
[TBL] [Abstract][Full Text] [Related]
8. Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan.
Rosa G; Ceccarini M; Cavaldesi M; Zini M; Petrucci TC
Biochem Biophys Res Commun; 1996 Jun; 223(2):272-7. PubMed ID: 8670271
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation as a regulator of dystrophin and beta-dystroglycan interaction: A molecular insight.
Abdullah M; Hassan A; Rashid S; Naeem M
J Mol Graph Model; 2020 Sep; 99():107623. PubMed ID: 32348939
[TBL] [Abstract][Full Text] [Related]
10. WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding.
Chung W; Campanelli JT
Mol Cell Biol Res Commun; 1999; 2(3):162-71. PubMed ID: 10662592
[TBL] [Abstract][Full Text] [Related]
11. The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle.
Bowe MA; Mendis DB; Fallon JR
J Cell Biol; 2000 Feb; 148(4):801-10. PubMed ID: 10684260
[TBL] [Abstract][Full Text] [Related]
12. Formation of multiple complexes between beta-dystroglycan and dystrophin family products.
Royuela M; Chazalette D; Hugon G; Paniagua R; Guerlavais V; Fehrentz JA; Martinez J; Labbe JP; Rivier F; Mornet D
J Muscle Res Cell Motil; 2003; 24(7):387-97. PubMed ID: 14677641
[TBL] [Abstract][Full Text] [Related]
13. Dystroglycan: brain localisation and chromosome mapping in the mouse.
Górecki DC; Derry JM; Barnard EA
Hum Mol Genet; 1994 Sep; 3(9):1589-97. PubMed ID: 7833916
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopic observations of triple immunogold labelling for dystrophin, beta-dystroglycan and adhalin in human skeletal myofibers.
Inoue M; Wakayama Y; Murahashi M; Shibuya S; Jimi T; Kojima H; Oniki H
Acta Neuropathol; 1996 Dec; 92(6):569-75. PubMed ID: 8960314
[TBL] [Abstract][Full Text] [Related]
15. Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo.
Sotgia F; Bonuccelli G; Bedford M; Brancaccio A; Mayer U; Wilson MT; Campos-Gonzalez R; Brooks JW; Sudol M; Lisanti MP
Biochemistry; 2003 Jun; 42(23):7110-23. PubMed ID: 12795607
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.
Swiderski K; Shaffer SA; Gallis B; Odom GL; Arnett AL; Scott Edgar J; Baum DM; Chee A; Naim T; Gregorevic P; Murphy KT; Moody J; Goodlett DR; Lynch GS; Chamberlain JS
Hum Mol Genet; 2014 Dec; 23(25):6697-711. PubMed ID: 25082828
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.
Jayasinha V; Nguyen HH; Xia B; Kammesheidt A; Hoyte K; Martin PT
Neuromuscul Disord; 2003 Jun; 13(5):365-75. PubMed ID: 12798792
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members.
Sotgia F; Lee JK; Das K; Bedford M; Petrucci TC; Macioce P; Sargiacomo M; Bricarelli FD; Minetti C; Sudol M; Lisanti MP
J Biol Chem; 2000 Dec; 275(48):38048-58. PubMed ID: 10988290
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of dystrophin and beta-dystroglycan demonstrated in en face view by double immunogold labeling of freeze-fractured skeletal muscle.
Cullen MJ; Walsh J; Stevenson SA; Rothery S; Severs NJ
J Histochem Cytochem; 1998 Aug; 46(8):945-54. PubMed ID: 9671444
[TBL] [Abstract][Full Text] [Related]
20. Direct interaction of beta-dystroglycan with F-actin.
Chen YJ; Spence HJ; Cameron JM; Jess T; Ilsley JL; Winder SJ
Biochem J; 2003 Oct; 375(Pt 2):329-37. PubMed ID: 12892561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
